Fatal dabigatran-associated bleeding

American Journal of Health-System Pharmacy

Volumn 71, Issue 5, 2014, Pages 360-

  Conway, Susan E ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APIXABAN; DABIGATRAN; DIPYRIDAMOLE; FRESH FROZEN PLASMA; PHYTOMENADIONE; PROTHROMBIN COMPLEX; RIVAROXABAN; WARFARIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; DRUG DERIVATIVE;

CHADS2 SCORE; DRUG FATALITY; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; LOADING DRUG DOSE; PRESCRIPTION; RISK ASSESSMENT; TREATMENT RESPONSE; BLEEDING; CHEMICALLY INDUCED DISORDER; FEMALE; NOTE;

BENZIMIDAZOLES; BETA-ALANINE; FEMALE; HEMORRHAGE; HUMANS;

EID: 84907189376     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp130735     Document Type: Letter

References (9)

1. Ageno W, Gallus AS, Wittkowsky A et al. Oral anticoagulation therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141:e44S-88S.
2. Pradaxa (dabigatran) product information. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals; 2013 Apr.
3. Eikelboom JW, Wallentin L, Connolly SJ et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation. 2011; 123:2363-72.
4. Hylek EM, Regan S, Go AS et al. Clinical predictors of prolonged delay in return of the International Normalized Ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med. 2001; 135:393-400.
5. Van Ryn J, Stangier J, Haetter S et al. Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulation activity. Thromb Haemost. 2010; 103:1116-27.
6. Cano EL, Miyares MA. Clinical challenges in a patient with dabigatran-induced fatal hemorrhage. Am J Geriatr Pharmacother. 2012; 10:160-3.
7. Béné J, Said W, Rannou M et al. Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients. Ann Pharmacother. 2012; 46:e14.
8. Wychowski M, Kouides PA. Dabigatraninduced gastrointestinal bleeding in an elderly patient with moderate renal impairment. Ann Pharmacother. 2012; 46:e10.
9. Legrand M, Mateo J, Aribaud A et al. The use of dabigatran in elderly patients. Arch Intern Med. 2011; 171:1285-8.